InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Autolus Therapeutics plc

AUTL Clue Score53
United Kingdom Fiscal year ends December CIK 0001730463
$1.81 +2.26% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.81 −69.22% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 22 Jun 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue1.7Operating income−23.4Net income−19.7Fiscal year 2018Revenue1.4 −16.9%Operating income−57.5Net income−44.8Fiscal year 2019Revenue2.9 +106.7%Operating income−146.1Net income−123.8EPS, diluted−2.88Fiscal year 2020Operating income−168.1Net income−142.1EPS, diluted−2.76Fiscal year 2021Operating income−141.1Net income−142.1EPS, diluted−1.97Fiscal year 2022Operating income−143.4Net income−148.8EPS, diluted−1.57Fiscal year 2023Revenue1.7Operating income−179.7Net income−208.4EPS, diluted−1.20Fiscal year 2024Revenue10.1 +496.0%Operating income−241.4Net income−220.7EPS, diluted−0.86Fiscal year 2025Revenue75.4 +644.9%Operating income−270.5Net income−287.5EPS, diluted−1.08
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.7 1.4 2.9 n/a n/a n/a 1.7 10.1 75.4
Growth −16.9% +106.7% +496.0% +644.9%
Operating income −23.4 −57.5 −146.1 −168.1 −141.1 −143.4 −179.7 −241.4 −270.5
Net income −19.7 −44.8 −123.8 −142.1 −142.1 −148.8 −208.4 −220.7 −287.5
Growth
EPS, diluted n/a n/a −2.88 −2.76 −1.97 −1.57 −1.20 −0.86 −1.08

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin−1,383.2%Net margin−1,165.2%Free cash flow margin−1,136.2%Fiscal year 2018Operating margin−4,089.1%Net margin−3,180.6%Free cash flow margin−2,889.6%Fiscal year 2019Operating margin−5,022.8%Net margin−4,258.9%Free cash flow margin−4,120.5%Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Operating margin−10,583.1%Net margin−12,272.3%Free cash flow margin−9,221.0%Fiscal year 2024Operating margin−2,385.6%Net margin−2,180.5%Free cash flow margin−2,256.4%Fiscal year 2025Operating margin−358.9%Net margin−381.4%Free cash flow margin−401.4%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −1,383.2% −4,089.1% −5,022.8% n/a n/a n/a −10,583.1% −2,385.6% −358.9%
Net margin −1,165.2% −3,180.6% −4,258.9% n/a n/a n/a −12,272.3% −2,180.5% −381.4%
Free cash flow margin −1,136.2% −2,889.6% −4,120.5% n/a n/a n/a −9,221.0% −2,256.4% −401.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−16.4Capital expenditure−2.9Free cash flow−19.2Fiscal year 2018Operating cash flow−31.5Capital expenditure−9.1Free cash flow−40.7Fiscal year 2019Operating cash flow−101.5Capital expenditure−18.3Free cash flow−119.8Fiscal year 2020Operating cash flow−117.8Capital expenditure−14.7Free cash flow−132.4Fiscal year 2021Operating cash flow−117.9Capital expenditure−8.9Free cash flow−126.7Fiscal year 2022Operating cash flow−112.3Capital expenditure−10.8Free cash flow−123.1Fiscal year 2023Operating cash flow−145.6Capital expenditure−11.0Free cash flow−156.6Fiscal year 2024Operating cash flow−206.3Capital expenditure−22.1Free cash flow−228.3Fiscal year 2025Operating cash flow−283.6Capital expenditure−19.0Free cash flow−302.6
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −16.4 −31.5 −101.5 −117.8 −117.9 −112.3 −145.6 −206.3 −283.6
Capital expenditure −2.9 −9.1 −18.3 −14.7 −8.9 −10.8 −11.0 −22.1 −19.0
Free cash flow −19.2 −40.7 −119.8 −132.4 −126.7 −123.1 −156.6 −228.3 −302.6
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash137.1Total debt0.8Net cash (debt)136.3Shareholders’ equity142.6Debt to equity0.01Fiscal year 2018Cash247.1Total debt0.4Net cash (debt)246.7Shareholders’ equity255.5Debt to equity0.00Fiscal year 2019Cash211.4Total debt0.0Net cash (debt)211.4Shareholders’ equity254.8Debt to equity0.00Fiscal year 2020Cash154.1Shareholders’ equity210.0Fiscal year 2021Cash310.3Shareholders’ equity313.3Fiscal year 2022Cash382.4Shareholders’ equity298.7Fiscal year 2023Cash239.6Shareholders’ equity111.5Fiscal year 2024Cash227.4Shareholders’ equity427.3Fiscal year 2025Cash104.1Shareholders’ equity178.1
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 137.1 247.1 211.4 154.1 310.3 382.4 239.6 227.4 104.1
Total debt 0.8 0.4 0.0 n/a n/a n/a n/a n/a n/a
Net cash (debt) 136.3 246.7 211.4 n/a n/a n/a n/a n/a n/a
Shareholders’ equity 142.6 255.5 254.8 210.0 313.3 298.7 111.5 427.3 178.1
Debt to equity 0.01 0.00 0.00 n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Sep 2017 FY2018 30 Sep 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
1.7 1.4 2.9 n/a n/a n/a 1.7 10.1 75.4
Growth −16.9% +106.7% +496.0% +644.9%
n/a n/a n/a n/a n/a n/a 0.0 11.4 96.4
16.0 36.2 105.4 134.9 110.8 117.4 130.5 138.4 117.7
9.1 22.8 39.5 35.0 31.9 31.9 46.7 101.7 131.9
−23.4 −57.5 −146.1 −168.1 −141.1 −143.4 −179.7 −241.4 −270.5
Growth
−23.4 −52.0 −139.0 −166.3 −142.0 −148.6 −208.4 −219.1 −285.6
−3.7 −7.3 −15.2 −24.2 0.1 0.3 −0.0 1.5 2.0
−19.7 −44.8 −123.8 −142.1 −142.1 −148.8 −208.4 −220.7 −287.5
Growth
Per share
n/a n/a −2.88 −2.76 −1.97 −1.57 −1.20 −0.86 −1.08
n/a n/a −2.88 −2.76 −1.97 −1.57 −1.20 −0.86 −1.08
Growth
n/a n/a 43.1 51.6 72.1 95.0 173.9 255.2 266.1
n/a n/a 43.1 51.6 72.1 95.0 173.9 255.2 266.1
Growth +19.7% +39.8% +31.8% +83.1% +46.7% +4.3%

† The diluted share count jumps at 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 113.7% a year over five years.
  • Operating margin is up 1,024.4 points on five years ago, at -358.9%.
  • A net loss in 9 of 9 years on file.